Full Text View
Tabular View
No Study Results Posted
Related Studies
Additivity Study: Additive Effect on Eye Pressure of Azopt and Alphagan P to Travatan
This study has been completed.
Study NCT00121147   Information provided by Hermann Eye Center
First Received: July 13, 2005   Last Updated: February 22, 2006   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Open Angle Glaucoma
Ocular Hypertension
Pseudoexfoliation Syndrome
Additional conditions recognized in this trial
Exfoliation Syndrome
Glaucoma
Glaucoma, Open-Angle
Hypertension
Syndrome
More general conditions related to this trial
Cardiovascular Diseases
Disease
Eye Diseases
Iris Diseases
Pathologic Processes
Uveal Diseases
Vascular Diseases
Interventions listed in this trial
Travatan
Azopt
Alphagan P
Additional drug interventions recognized in this trial
Brimonidine
Brinzolamide
Travoprost
More general drug interventions related to this trial
Adrenergic Agents
Adrenergic Agonists
Adrenergic alpha-Agonists
Antihypertensive Agents
Carbonic Anhydrase Inhibitors
Cardiovascular Agents
Enzyme Inhibitors
Molecular Mechanisms of Pharmacological Action
Neurotransmitter Agents
Pharmacologic Actions
Physiological Effects of Drugs
Therapeutic Uses
Sponsors listed in this trial
Hermann Eye Center
Alcon Research


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services